Patient Capital
Patient capital refers to investment funds willing to accept extended investment horizons without pursuing short-term rapid exits. It is commonly deployed in deep tech, infrastructure, and other domains requiring prolonged research and development accumulation, and is typically structured through evergreen funds or government-guided investment vehicles.
Timeline (last 90 days)
Building a frontier ecosystem requires the synergy of three pillars: technology, talent and capital: at the technology level, continuous investment in basic research and application development; at the talent level, cultivating interdisciplinary composite talent and establishing flexible mobility mechanisms; at the capital level, patient capital and diversified financing channels are needed.
Patient capital refers to a form of capital that does not take short-term financial returns as its primary goal and is willing to bear longer investment cycles and higher uncertainty; typical sources include sovereign wealth funds, pension funds, university endowment funds, government industry guidance funds and family offices, among others.
Traditional venture capital usually requires exit within 7-10 years, whereas patient capital can accompany hard-tech and deep-tech enterprises through R&D and commercialization cycles of more than 10 years.
In the robotics field, going from technology validation to mass-production deployment typically takes 5 to 10 years, far exceeding the growth cycle of software companies.
All Facts (4)
Building a frontier ecosystem requires the synergy of three pillars: technology, talent and capital: at the technology level, continuous investment in basic research and application development; at the talent level, cultivating interdisciplinary composite talent and establishing flexible mobility mechanisms; at the capital level, patient capital and diversified financing channels are needed.
50%UnverifiedPatient capital refers to a form of capital that does not take short-term financial returns as its primary goal and is willing to bear longer investment cycles and higher uncertainty; typical sources include sovereign wealth funds, pension funds, university endowment funds, government industry guidance funds and family offices, among others.
50%UnverifiedTraditional venture capital usually requires exit within 7-10 years, whereas patient capital can accompany hard-tech and deep-tech enterprises through R&D and commercialization cycles of more than 10 years.
50%UnverifiedIn the robotics field, going from technology validation to mass-production deployment typically takes 5 to 10 years, far exceeding the growth cycle of software companies.
50%